Stefan MAZY
CEO Founder - Derma Health Solutions Pty Ltd (AUSTRALIA)
SkinRNA Micro-cell Test
A world-first, repeatable, epigenetic diagnostic skin patch and laboratory test that quantifies skincare effectiveness via real-time gene expression activity. Our device collects more than 15,000 genes, while our algorithms provide gene expression activity scores for skin functions including collagen and elastin production, and skin inflammation. After product intervention, a second test is performed measuring new gene activity against initial benchmarks. Consumers can then repeat testing at intervals to track and monitor skin improvement at a genetic level without waiting for visible signs.